PR

Promakhos Therapeutics

YC S21

Boston, US · Founded 2021 · 2 employees · 1 known investors

promakhos.com ↗

Promakhos Therapeutics develops immunomodulatory therapies to restore immune system balance and reduce chronic inflammation in diseases like Crohn's disease, ankylosing spondylitis, and psoriasis. The company targets patients with inflammatory diseases who do not benefit from current immunosuppressive treatments.

Founders & leadership· Y Combinator alumni (S21)

Katerina ChatziinCo-founder, Chief Executive Officer and President

Jasper Edgar NeggersinFounder

JE

Jasper E. NeggersCo-Founder, Chief Scientific Officer and Secretary

Investors · 1

Y

Y CombinatorMountain View · $500K – $500K